HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹254 Cr | ₹233 Cr | ₹198 Cr | ₹114 Cr | ₹97 Cr |
What is the latest Total Non-Current Liabilities ratio of HESTER BIOSCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹254 Cr |
Mar2023 | ₹233 Cr |
Mar2022 | ₹198 Cr |
Mar2021 | ₹114 Cr |
Mar2020 | ₹97 Cr |
How is Total Non-Current Liabilities of HESTER BIOSCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹254 Cr | 9.01 | |
Mar2023 | ₹233 Cr | 17.61 | |
Mar2022 | ₹198 Cr | 73.99 | |
Mar2021 | ₹114 Cr | 17.67 | |
Mar2020 | ₹97 Cr | - |
Compare Total Non-Current Liabilities of peers of HESTER BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HESTER BIOSCIENCES | ₹1,536.4 Cr | 0.8% | -2.9% | -33.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
HESTER BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HESTER BIOSCIENCES | 0.8% |
-2.9% |
-33.2% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses